Literature DB >> 20514438

Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas.

Kouji Ohta1, Ikuko Ogawa, Shigehiro Ono, Masaaki Taki, Kuniko Mizuta, Miwa Miyauchi, Masaaki Takechi, Hideo Shigeishi, Takashi Takata, Nobuyuki Kamata.   

Abstract

Lugol's iodine staining (Lugol-staining) has been widely used to detect malignant changes in the cervix uteri and esophagus. However, pathological and histochemical changes in the border between Lugol-stained and -unstained areas in oral epithelial dysplastia and malignant lesions are not well understood. We examined the histological appearance of 20 cases of epithelial dysplasia surrounding squamous cell carcinoma using HE and PAS staining in the borders between Lugol-stained and -unstained areas. Subsequently, differences in the expression of cytokeratin 13 (CK13), an epithelium differentiation marker, and Ki-67, a cell proliferative marker, in those areas were investigated by immunohistochemistry. Lugol-stained areas of all cases showed mild dysplasia or normal epithelium appearance, while Lugol-unstained areas in most cases were diagnosed as moderate/severe dysplasia and carcinoma in situ. PAS reactions were limited or not found in the Lugol-unstained areas as compared to intense positivity in Lugol-stained areas. CK13 and Ki-67 protein expression was significantly different between Lugol-stained and -unstained areas. It was confirmed that epithelia showing precancerous or cancerous features were detected as Lugol-unstained boundary areas. A reduction in glycogen production caused by alterations of cell differentiation and proliferation associated with malignant changes may result in a lack of Lugol-staining.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514438     DOI: 10.3892/or_00000822

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Clinical relevance of the utilization of vital Lugol's iodine staining in detection and diagnosis of oral cancer and dysplasia.

Authors:  Imad Elimairi; Mehmet Ali Altay; Omer Abdoun; Amr Elimairi; Sinan Tozoglu; Dale A Baur; Faisal Quereshy
Journal:  Clin Oral Investig       Date:  2016-08-05       Impact factor: 3.573

2.  Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1.

Authors:  Tiepeng Xiao; Hiroshi Kurita; Tetsu Shimane; Yoshitaka Nakanishi; Takeshi Koike
Journal:  Int J Clin Oncol       Date:  2012-07-25       Impact factor: 3.402

3.  Loss of cytokeratin 10 indicates malignant transformation in actinic cheilitis.

Authors:  Natália Galvão Garcia; Denise Tostes Oliveira; José Roberto Pereira Lauris; Maria Aparecida Custódio Domingues; Eliana Maria Minicucci; Cléverson Teixeira Soares
Journal:  Clin Oral Investig       Date:  2015-08-13       Impact factor: 3.573

4.  Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma.

Authors:  Ryoji Kitamura; Takeshi Toyoshima; Hideaki Tanaka; Shintaro Kawano; Takahiro Kiyosue; Ryota Matsubara; Yuichi Goto; Mitsuhiro Hirano; Kazunari Oobu; Seiji Nakamura
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-03       Impact factor: 4.553

5.  Intraoperative assessment of surgical margins of oral squamous cell carcinoma using frozen sections: a practical clinicopathological management for recurrences.

Authors:  Shun Miyota; Takanori Kobayashi; Tatsuya Abé; Hisashi Miyajima; Masaki Nagata; Hideyuki Hoshina; Tadaharu Kobayashi; Ritsuo Takagi; Takashi Saku
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.